BioMarin

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade BioMarin 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BMRN

BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307. 

CEO
Alexander Hardy
CEOAlexander Hardy
Employees
3,040
Employees3,040
Headquarters
San Rafael, California
HeadquartersSan Rafael, California
Founded
1997
Founded1997
Employees
3,040
Employees3,040

BMRN Key Statistics

Market cap
12.96B
Market cap12.96B
Price-Earnings ratio
32.03
Price-Earnings ratio32.03
Dividend yield
Dividend yield
Average volume
1.61M
Average volume1.61M
High today
$70.80
High today$70.80
Low today
$67.85
Low today$67.85
Open price
$70.20
Open price$70.20
Volume
1.24M
Volume1.24M
52 Week high
$94.85
52 Week high$94.85
52 Week low
$60.63
52 Week low$60.63

BMRN News

Simply Wall St 2d
The Price Is Right For BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc.'s ( ) price-to-earnings (or "P/E") ratio of 31.9x might make it look like a strong sell right now compared to the market in the Uni...

The Price Is Right For BioMarin Pharmaceutical Inc.

Analyst ratings

81%

of 31 ratings
Buy
80.6%
Hold
19.4%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.